Correlation Between Materials Analysis and Medigen Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Materials Analysis and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Materials Analysis and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Materials Analysis Technology and Medigen Biotechnology, you can compare the effects of market volatilities on Materials Analysis and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Materials Analysis with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Materials Analysis and Medigen Biotechnology.

Diversification Opportunities for Materials Analysis and Medigen Biotechnology

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Materials and Medigen is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Materials Analysis Technology and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Materials Analysis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Materials Analysis Technology are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Materials Analysis i.e., Materials Analysis and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between Materials Analysis and Medigen Biotechnology

Assuming the 90 days trading horizon Materials Analysis Technology is expected to under-perform the Medigen Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Materials Analysis Technology is 1.02 times less risky than Medigen Biotechnology. The stock trades about -0.19 of its potential returns per unit of risk. The Medigen Biotechnology is currently generating about -0.13 of returns per unit of risk over similar time horizon. If you would invest  3,730  in Medigen Biotechnology on October 20, 2024 and sell it today you would lose (470.00) from holding Medigen Biotechnology or give up 12.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Materials Analysis Technology  vs.  Medigen Biotechnology

 Performance 
       Timeline  
Materials Analysis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Materials Analysis Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Medigen Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Materials Analysis and Medigen Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Materials Analysis and Medigen Biotechnology

The main advantage of trading using opposite Materials Analysis and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Materials Analysis position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.
The idea behind Materials Analysis Technology and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stocks Directory
Find actively traded stocks across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios